Robert G. Feldman, M.D. - Publications

Affiliations: 
Neurology Boston University School of Medicine, Boston, MA 
Area:
Neurotoxicology, Parkinson's disease

47 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Ratner MH, Farb DH, Ozer J, Feldman RG, Durso R. Younger age at onset of sporadic Parkinson's disease among subjects occupationally exposed to metals and pesticides. Interdisciplinary Toxicology. 7: 123-33. PMID 26109889 DOI: 10.2478/Intox-2014-0017  0.745
2005 Karamohamed S, Golbe LI, Mark MH, Lazzarini AM, Suchowersky O, Labelle N, Guttman M, Currie LJ, Wooten GF, Stacy M, Saint-Hilaire M, Feldman RG, Liu J, Shoemaker CM, Wilk JB, et al. Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 1188-91. PMID 15966003 DOI: 10.1002/Mds.20515  0.316
2002 Siderowf A, Stern M, Shoulson I, Kieburtz K, Oakes D, Day D, Shinaman A, Plumb S, Fahn S, Blindauer K, Lew M, Hurtig H, Lloyd M, Hauser R, Gauger L, ... ... Feldman R, et al. A controlled trial of rasagiline in early Parkinson disease: The tempo study Archives of Neurology. 59: 1937-1943. PMID 12470183 DOI: 10.1001/Archneur.59.12.1937  0.331
2002 Maher NE, Currie LJ, Lazzarini AM, Wilk JB, Taylor CA, Saint-Hilaire MH, Feldman RG, Golbe LI, Wooten GF, Myers RH. Segregation analysis of Parkinson disease revealing evidence for a major causative gene. American Journal of Medical Genetics. 109: 191-7. PMID 11977177 DOI: 10.1002/Ajmg.10335  0.321
2002 DeStefano AL, Lew MF, Golbe LI, Mark MH, Lazzarini AM, Guttman M, Montgomery E, Waters CH, Singer C, Watts RL, Currie LJ, Wooten GF, Maher NE, Wilk JB, Sullivan KM, ... ... Feldman RG, et al. PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study. American Journal of Human Genetics. 70: 1089-95. PMID 11920285 DOI: 10.1086/339814  0.301
2002 Maher NE, Golbe LI, Lazzarini AM, Mark MH, Currie LJ, Wooten GF, Saint-Hilaire M, Wilk JB, Volcjak J, Maher JE, Feldman RG, Guttman M, Lew M, Waters CH, Schuman S, et al. Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study. Neurology. 58: 79-84. PMID 11781409 DOI: 10.1212/Wnl.58.1.79  0.337
2001 Feldman RG, Ratner MH. Essentials of metal neurotoxicity: Mechanisms and pathology Clinics in Occupational and Environmental Medicine. 1: 619-653.  0.442
1999 Feldman RG, Ratner MH. The pathogenesis of neurodegenerative disease: neurotoxic mechanisms of action and genetics. Current Opinion in Neurology. 12: 725-31. PMID 10676756 DOI: 10.1097/00019052-199912000-00012  0.546
1999 Taylor CA, Saint-Hilaire MH, Cupples LA, Thomas CA, Burchard AE, Feldman RG, Myers RH. Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study. American Journal of Medical Genetics. 88: 742-9. PMID 10581500 DOI: 10.1002/(Sici)1096-8628(19991215)88:6<742::Aid-Ajmg29>3.0.Co;2-#  0.316
1999 Feldman RG, Ratner MH, Ptak T. Chronic toxic encephalopathy in a painter exposed to mixed solvents. Environmental Health Perspectives. 107: 417-22. PMID 10210698 DOI: 10.1289/Ehp.99107417  0.591
1999 Feldman RG, Ratner MH, Feldman ES. Approach to neurotoxicity tort cases. Neurologic Clinics. 17: 267-81. PMID 10196408 DOI: 10.1016/S0733-8619(05)70130-4  0.543
1997 White RF, Feldman RG, Eviator II, Jabre JF, Niles CA. Hazardous waste and neurobehavioral effects: a developmental perspective. Environmental Research. 73: 113-24. PMID 9311537 DOI: 10.1006/Enrs.1997.3699  0.562
1996 Feldman RG, White RF. Role of the neurologist in hazard identification and risk assessment. Environmental Health Perspectives. 104: 227-37. PMID 9182031 DOI: 10.1289/Ehp.96104S2227  0.584
1996 White RF, Diamond R, Krengel M, Lindem K, Feldman RG, Letz R, Eisen E, Wegman D. Validation of the NES2 in patients with neurologic disorders. Neurotoxicology and Teratology. 18: 441-8. PMID 8866536 DOI: 10.1016/0892-0362(96)00021-9  0.552
1996 Fiedler N, Feldman RG, Jacobson J, Rahill A, Wetherell A. The assessment of neurobehavioral toxicity: SGOMSEC joint report. Environmental Health Perspectives. 104: 179-91. PMID 8860321 DOI: 10.1289/Ehp.96104S2179  0.338
1995 White RF, Proctor SP, Echeverria D, Schweikert J, Feldman RG. Neurobehavioral effects of acute and chronic mixed-solvent exposure in the screen printing industry. American Journal of Industrial Medicine. 28: 221-31. PMID 8585519 DOI: 10.1002/Ajim.4700280207  0.565
1995 Diamond R, White RF, Gerr F, Feldman RG. A Case of Developmental Exposure to Inorganic Mercury Child Neuropsychology. 1: 140-149. DOI: 10.1080/09297049508402245  0.555
1993 White RF, Feldman RG, Moss MB, Proctor SP. Magnetic resonance imaging (MRI), neurobehavioral testing, and toxic encephalopathy: two cases. Environmental Research. 61: 117-23. PMID 8472665 DOI: 10.1006/Enrs.1993.1055  0.539
1993 Durso R, Isaac K, Perry L, Saint-Hilaire M, Feldman RG. Age influences magnitude but not duration of response to levodopa. Journal of Neurology, Neurosurgery, and Psychiatry. 56: 65-8. PMID 8429325  0.62
1993 Feldman RG, White RF, Eriator II. Trimethyltin encephalopathy. Archives of Neurology. 50: 1320-4. PMID 8257310 DOI: 10.1001/archneur.1993.00540120035010  0.515
1992 Feldman RG. Manganese as possible ecoetiologic factor in Parkinson's disease. Annals of the New York Academy of Sciences. 648: 266-7. PMID 1637054 DOI: 10.1111/J.1749-6632.1992.Tb24552.X  0.314
1992 Price MJ, Feldman RG, Adelberg D, Kayne H. Abnormalities in color vision and contrast sensitivity in Parkinson's disease. Neurology. 42: 887-90. PMID 1565248 DOI: 10.1212/Wnl.42.4.887  0.34
1992 Feldman RG, Niles C, Proctor SP, Jabre J. Blink reflex measurement of effects of trichloroethylene exposure on the trigeminal nerve. Muscle & Nerve. 15: 490-5. PMID 1565117 DOI: 10.1002/Mus.880150413  0.342
1992 Feldman RG, White RF. Lead neurotoxicity and disorders of learning. Journal of Child Neurology. 7: 354-9. PMID 1469241 DOI: 10.1177/088307389200700404  0.549
1990 White RF, Feldman RG, Travers PH. Neurobehavioral effects of toxicity due to metals, solvents, and insecticides. Clinical Neuropharmacology. 13: 392-412. PMID 2272020 DOI: 10.1097/00002826-199010000-00002  0.494
1990 Baker EL, Feldman RG, French JG. Environmentally related disorders of the nervous system. The Medical Clinics of North America. 74: 325-45. PMID 2157116 DOI: 10.1016/S0025-7125(16)30565-X  0.333
1990 Saint-Hilaire M, Feldman RG, Durso R. Deprenyl for the treatment of early Parkinson's disease (IV) New England Journal of Medicine. 322: 1527.  0.595
1989 Durso R, Szabo G, Davoudi H, Feldman RG. Magnitude of response to levodopa in Parkinson disease as it relates to peripheral and central measurements of levodopa and associated metabolites. Clinical Neuropharmacology. 12: 384-92. PMID 2611763 DOI: 10.1097/00002826-198910000-00003  0.609
1987 White RF, Feldman RG. Neuropsychological assessment of toxic encephalopathy. American Journal of Industrial Medicine. 11: 395-8. PMID 3578292  0.445
1985 Feldman RG, White RF, Currie JN, Travers PH, Lessell S. Long-term follow-up after single toxic exposure to trichloroethylene. American Journal of Industrial Medicine. 8: 119-26. PMID 4050794 DOI: 10.1002/Ajim.4700080206  0.557
1985 Baker EL, White RF, Pothier LJ, Berkey CS, Dinse GE, Travers PH, Harley JP, Feldman RG. Occupational lead neurotoxicity: improvement in behavioural effects after reduction of exposure. British Journal of Industrial Medicine. 42: 507-16. PMID 4016002 DOI: 10.1136/Oem.42.8.507  0.558
1984 Harrigan EP, McLaughlin TJ, Feldman RG. Transverse myelitis due to meningovascular syphilis. Archives of Neurology. 41: 337-8. PMID 6696656 DOI: 10.1001/Archneur.1984.04050150119030  0.3
1984 Freedman M, Rivoira P, Butters N, Sax DS, Feldman RG. Retrograde amnesia in Parkinson's disease. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 11: 297-301. PMID 6234056  0.514
1983 Baker EL, Feldman RG, White RF, Harley JP, Dinse GE, Berkey CS. Monitoring neurotoxins in industry: development of a neurobehavioral test battery. Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association. 25: 125-30. PMID 6834160  0.495
1983 Baker EL, Feldman RG, White RF, Harley JP. The role of occupational lead exposure in the genesis of psychiatric and behavioral disturbances. Acta Psychiatrica Scandinavica. Supplementum. 303: 38-48. PMID 6575582 DOI: 10.1111/J.1600-0447.1983.Tb00940.X  0.563
1983 Browne TR, Feldman RG, Buchanan RA, Allen NC, Fawcett-Vickers L, Szabo GK, Mattson GF, Norman SE, Greenblatt DJ. Methsuximide for complex partial seizures: efficacy, toxicity, clinical pharmacology, and drug interactions. Neurology. 33: 414-8. PMID 6403891 DOI: 10.1212/Wnl.33.4.414  0.605
1982 Baker EL, Feldman RG. Paraoccupational exposure to mixed solvents. Journal of Toxicology. Clinical Toxicology. 19: 27-34. PMID 7154139 DOI: 10.3109/15563658208990363  0.347
1980 Direnfeld LK, Feldman RG, Alexander MP, Kelly-Hayes M. Is L-DOPA drug holiday useful? Neurology. 30: 785-8. PMID 7190248 DOI: 10.1212/Wnl.30.7.785  0.302
1980 Kreiss K, Wegman DH, Niles CA, Siroky MB, Krane RJ, Feldman RG. Neurological dysfunction of the bladder in workers exposed to dimethylaminopropionitrile. Jama. 243: 741-5. PMID 6243373 DOI: 10.1001/Jama.1980.03300340017012  0.312
1979 Oscar-Berman M, Gade A, Feldman RG, Saavedra MA. Effects of dimepramine fumarate on physiological and cognitive behaviors of Parkinson patients. Journal of Clinical Pharmacology. 19: 626-34. PMID 512060 DOI: 10.1002/J.1552-4604.1979.Tb01625.X  0.343
1979 Appenzeller O, Feldman RG, Friedman AP. Migraine, headache, and related conditions--panel 7. Archives of Neurology. 36: 784-805. PMID 508144 DOI: 10.1001/Archneur.1979.00500480058009  0.309
1979 Feldman RG, Culebras A, Schmidek HH. Paget's disease and the nervous system. Journal of the American Geriatrics Society. 27: 1-8. PMID 215614 DOI: 10.1111/J.1532-5415.1979.Tb01712.X  0.306
1978 Feldman RG, Kelly-Hayes M, Conomy JP, Foley JM. Baclofen for spasticity in multiple sclerosis. Double-blind crossover and three-year study. Neurology. 28: 1094-8. PMID 362234 DOI: 10.1212/Wnl.28.11.1094  0.309
1977 Feldman RG, Hayes MK, Younes R, Aldrich FD. Lead neuropathy in adults and children. Archives of Neurology. 34: 481-8. PMID 889480 DOI: 10.1001/Archneur.1977.00500200041008  0.327
1977 Sax DS, Johnson TL, Feldman RG. L‐dopa effects on H‐reflex recovery in Parkinson's disease Annals of Neurology. 2: 120-124. DOI: 10.1002/Ana.410020206  0.315
1974 Culebras A, Feldman RG, Fager CA. Hydrocephalus and dementia in Paget's disease of the skull. Journal of the Neurological Sciences. 23: 307-21. PMID 4427119 DOI: 10.1016/0022-510X(74)90233-0  0.342
1972 Lamarche JB, Behan PO, Segarra JM, Feldman RG. Recurrent acute necrotizing hemorrhagic incephalopathy. Acta Neuropathologica. 22: 79-87. PMID 5083841 DOI: 10.1007/Bf00687552  0.304
Show low-probability matches.